Value assessment of immuno-oncology in the treatment of rare tumors in the era of accelerated conditional approvals

Future Oncology, Ahead of Print.

Source: Future Oncology - November 4, 2019 Category: Cancer & Oncology Authors: Tereza Lanitis Apoorva Ambavane Ying Zheng Michael Schlichting Hemant Phatak Source Type: research